0000950170-24-061276.txt : 20240516
0000950170-24-061276.hdr.sgml : 20240516
20240516185739
ACCESSION NUMBER: 0000950170-24-061276
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240515
FILED AS OF DATE: 20240516
DATE AS OF CHANGE: 20240516
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Patterson Joshua F.
CENTRAL INDEX KEY: 0001805702
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-41925
FILM NUMBER: 24957282
MAIL ADDRESS:
STREET 1: C/O GAMIDA CELL LTD.
STREET 2: 116 HUNTINGTON AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02116
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CG Oncology, Inc.
CENTRAL INDEX KEY: 0001991792
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 371611499
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 400 SPECTRUM CENTER DRIVE
STREET 2: SUITE 2040
CITY: IRVINE
STATE: CA
ZIP: 92618
BUSINESS PHONE: (949) 419-6203
MAIL ADDRESS:
STREET 1: 400 SPECTRUM CENTER DRIVE
STREET 2: SUITE 2040
CITY: IRVINE
STATE: CA
ZIP: 92618
4
1
ownership.xml
4
X0508
4
2024-05-15
0001991792
CG Oncology, Inc.
CGON
0001805702
Patterson Joshua F.
C/O CG ONCOLOGY, INC.
400 SPECTRUM CENTER DRIVE, SUITE 2040
IRVINE
CA
92618
false
true
false
false
See Remarks
false
Stock Option (Right to Buy)
28.01
2024-05-15
4
A
false
100000
0
A
2034-05-14
Common Stock
100000
100000
D
The stock option vests as to 25% of the underlying shares on June 1, 2025, and as to the remaining of the underlying shares in 36 substantially similar monthly installments thereafter.
General Counsel and Chief Compliance Officer
/s/ Joshua F. Patterson
2024-05-16